Product information

From Health Canada

Current status:

Cancelled Pre Market

Current status date:

2021-04-29

Original market date: See footnote 1

Product name:

LYPSYL EXTREME

DIN:

02493209 Electronic product monograph is not available

Company:

LORNAMEAD, INC.
175 Cooper Avenue
Tonawanda
New York
United States 14150-6656

Class:

Human

Dosage form(s):

Stick

Route(s) of administration:

Topical

Number of active ingredient(s):

4

Schedule(s):

OTC

 

American Hospital Formulary Service (AHFS): See footnote 3

84:80.00 

Anatomical Therapeutic Chemical (ATC): See footnote 4

D02BA30 COMBINATIONS OF PROTECTIVES AGAINST UV-RADIATION

Active ingredient group (AIG) number:See footnote5

0439065020

List of active ingredient(s)
Active ingredient(s) Strength
AVOBENZONE 2 % / W/W
OCTINOXATE 7.5 % / W/W
OCTOCRYLENE 7 % / W/W
OXYBENZONE 5 % / W/W
Version 4.0.2
Date modified: